This biotech stock has jumped nearly 50% in 3 months. Its CEO says business is ‘growing substantially’
It's been a stellar few months for shares of San Francisco-based biotech company Rigel Pharmaceuticals, which has approved treatments for ...
It's been a stellar few months for shares of San Francisco-based biotech company Rigel Pharmaceuticals, which has approved treatments for ...
Investors are noticing ripe opportunity in Cytokinetics, a late-stage biopharma company targeting medicines for specialty heart diseases, that has seen ...
While insider buying is typically slower when markets are near all-time highs and when earnings-reporting season is in full swing, ...
Dublin-based Aerska, a biotechnology company specialising in the treatment of neurological diseases, announced its launch along with $21M (approximately €17.8M) ...
Artificial intelligence is already transforming industries from finance to manufacturing. But its biggest impact could come in healthcare, a field ...
© Copyright 2024 All Rights Reserved
See articles for original source and related links to external sites.
© Copyright 2024 All Rights Reserved
See articles for original source and related links to external sites.